NDC 15631-0330

PARIS QUADRIFOLIA

Paris Quadrifolia

PARIS QUADRIFOLIA is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Paris Quadrifolia.

Product ID15631-0330_47128fa6-2557-41b8-8968-37db79df84f1
NDC15631-0330
Product TypeHuman Otc Drug
Proprietary NamePARIS QUADRIFOLIA
Generic NameParis Quadrifolia
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2015-09-12
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRxhomeo Private Limited d.b.a. Rxhomeo, Inc
Substance NamePARIS QUADRIFOLIA
Active Ingredient Strength3 [hp_X]/1
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 15631-0330-0

100 PELLET in 1 PACKAGE (15631-0330-0)
Marketing Start Date2018-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15631-0330-3 [15631033003]

PARIS QUADRIFOLIA PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-24

NDC 15631-0330-5 [15631033005]

PARIS QUADRIFOLIA PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-24

NDC 15631-0330-4 [15631033004]

PARIS QUADRIFOLIA PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-24

NDC 15631-0330-1 [15631033001]

PARIS QUADRIFOLIA PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-24

NDC 15631-0330-2 [15631033002]

PARIS QUADRIFOLIA PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-24

NDC 15631-0330-0 [15631033000]

PARIS QUADRIFOLIA PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-24

Drug Details

Active Ingredients

IngredientStrength
PARIS QUADRIFOLIA3 [hp_X]/1

OpenFDA Data

SPL SET ID:a37db86e-81c1-4963-9657-b799b00e5a5c
Manufacturer
UNII

NDC Crossover Matching brand name "PARIS QUADRIFOLIA" or generic name "Paris Quadrifolia"

NDCBrand NameGeneric Name
0220-3928Paris quadrifoliaPARIS QUADRIFOLIA
15631-0330PARIS QUADRIFOLIAPARIS QUADRIFOLIA
37662-2322Paris QuadrifoliaParis Quadrifolia
37662-2323Paris QuadrifoliaParis Quadrifolia
37662-2324Paris QuadrifoliaParis Quadrifolia
37662-2325Paris QuadrifoliaParis Quadrifolia
37662-2326Paris QuadrifoliaParis Quadrifolia
37662-2327Paris QuadrifoliaParis Quadrifolia
37662-2328Paris QuadrifoliaParis Quadrifolia
37662-2329Paris QuadrifoliaParis Quadrifolia
37662-2330Paris QuadrifoliaParis Quadrifolia
68428-554Paris quadrifoliaPARIS QUADRIFOLIA
71919-520Paris quadrifoliaPARIS QUADRIFOLIA

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.